CANDO
Computational ANalytics of Novel Drug repurposing Oppertunities
Table of Contents
Overview
CANDO is a shotgun approach to drug repurposing that is developed to analyze the interactions all FDA and human ingestible compounds have on the proteome. The proteome-wide interaction signatures of drugs are compared agaisnt one another to identify compounds with similar proteome interactions. If a compound known to treat a given indication is match with a compound not known to treat this indication, then the platform suggests repurposing the second compound for the indication.